I have a close family member who had Covid, and experienced

New Post Public Reply Private Reply Replies (4) Message Board
CYDY_Invest
2,429
I have a close family member who had Covid, and experienced Long Haul symptoms. She recently was tested and treated with Bruce Patterson’s company IncellDx for Covid Long Haul, and she thinks it was a complete rip off. She’s intelligent, open minded, and was willing to give it a shot. After her initial sign up, some challenges up front were lack of/poor communication of where to get blood drawn. Finally someone from the company got back to her after they were contacted numerous times. (BTW, I think IncellDx’s website is not very organized and just doesn’t look good.)

Her Covid Long Haul panel tested abnormally high positive for 10 cytokine/chemokines and also positive for the Long Haul index algorithm. Her 2 current physicians (who are very smart well-trained doctors) weren’t comfortable prescribing the repurposed drugs that were recommended (Statins, Steroids, Ivermectin, etc). So, the only way to get the drugs prescribed were from 2 physicians that were in her area that IncellDx recommended (One was about to relocate). She went with the available doctor, and had to pay $750 (out of pocket) for treatment and follow up. She paid the $750 and took the recommended drugs for the duration suggested.

This doctor she used (referred by IncellDX) was completely incompetent. My family member asked her about the purpose of different drugs and for what elevated cytokines etc, and the doctor said absolutely nothing, didn’t have a clue about immunology. My family member mentioned she felt Ivermectin was giving her an upset stomach, and if it was okay to stop Ivermectin. The doctor had absolutely no opinion. Other questions she had the doctor didn’t say anything – was totally useless. Obviously, this was very upsetting to my family member.

She decided to stick with the recommended full treatment of drugs and duration and to see what happens with the follow up lab test. Will this help her abnormally high cytokines and Long Haul index score? The answer was no, not at all. We recently got the follow up test and it showed abnormally high positives now for 11 cytokine/chemokines and still positive for the LongHaul index score, so it actually got a little worse.

And symptomatically for her, nothing improved.

I know this is one patient's story, but I share this to mention that Patterson’s testing methodology and use of repurposed drugs is not proven. (13D group thinks Patterson has the holy grail answer to Covid Long Haul). There are no placebo control double blinded trials showing this works. I’m not trying to be a basher, just that this is unproven. I recently talked to my family member, and she repeated saying, “this was a total rip off.” She is pretty angry, and still suffering.

Also the lab tests IncellDx uses are not FDA reviewed or approved. They are called “Laboratory Developed Tests” (in the past LDTs were known as “Homebrew tests”), and they don’t carry the same weight of clinical evidence that FDA approved tests do. It's good to keep this in perspective.

I went over that IncellDx lab report from my family member which says below the data just to quote, “The LDT (laboratory developed test) tests comprising the panel has not been reviewed by the US FDA.”

I went to the FDA website to cite a reference to LDTs if anyone is interested:
https://www.fda.gov/media/102367/download

“Many stakeholders, in addition to FDA, have indicated that there is a public health need for greater oversight of LDTs.” (in the conclusion of the link)

The 13d group it seems has put Patterson on a pedestal with hero worship. Almost cult like praise, the group built around 1 person. They think his TedTalk caused the $10 sp spike. That’s crazy talk, such a reach. He’s not famous. Also, why the dump then? This was Covid stock season pump and dump. 13d claims they’ll get a fast enrollment for Long Haul Phase 3. Current management had a very fast Covid Long Haul Phase 2 fill up with Dr. Norman Gaylis (on the SAB who is extremely qualified, and not looking to take over the company). They had a record setting NASH Phase 2 enrollment. I expect current management to have a fast enrollment of Long Haul Phase 3, under Dr. Recknor.

13d brings nothing new, only a ton of risk. Let’s not give them the keys to the car. They say they have funding lined up and don’t talk to Big Pharma, however we have no way of knowing what they really are able to, and willing to do. Again, just to keep things in perspective, Patterson is not the only CCR5 expert. Do a PubMed search on CCR5 and you will get over 10,000 articles from scientists all over the world discussing CCR5. Also, there are now numerous Long Haul clinics and institutions researching this disease (not just IncellDx).

Many of us investors are not scientists and may not have technical expertise, however we can still make a good judgement about the future of our company.

I like our current management team together with the 8 highly qualified Scientific Board of Advisors. I like the progress and direction, and I know what to expect from them. I have a lot of shares and it’s in my financial interest to support them.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Jacob Walthour to Be Honored for Economic Leadership

Updated Category News Views 6

The Honoring of Leadership That Goes Beyond Business In a world where financial influence often feels like it funnels into the same familiar pockets, the news of Jacob Walthour Jr.'s upcoming recognition feels like a fresh breeze of change. The Alpha Phi Alpha's Alpha Alpha Lambda Chapter is rolling out the red carpet at its Centennial Gala for Walthour, throwing him into...

Continue Reading
Goddess Maintenance Co. Eyes BeautyMatter Award

Updated Category News Views 5

Challenging the Haircare Norm with Confidence Goddess Maintenance Co. doesn't just draft a fresh play in the beauty industry playbook—it's ripping out the old pages and setting a new standard. This ain't your granny's haircare game anymore, folks. They're up for a 2026 BeautyMatter Award, a nod to their gut-busting innovation in the conditioner category with their star...

Continue Reading
Koogler's Sale to ALL4: A Game-Changer for the Southeast

Updated Category News Views 6

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Continue Reading
Red Banyan Earns Top Honors in Florida for 2026

Updated Category News Views 6

Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...

Continue Reading
American Savings Bank IPO Hits NYSE: $129M Raised

Updated Category News Views 11

A Big Day for American Savings Bank Buckled up yet? Because American Savings Bank has just shot onto the NYSE, raising a hefty $129 million. A solid start, I’d say, for a Honolulu-based outfit that now struts around with a valuation tipping beyond $1.03 billion. That’s what you get when you price more than eight million shares at $16 a pop. NYSE:ASBH is the new kid on...

Continue Reading
Lyric Health's AI System Promises Data-Driven Revolution

Updated Category News Views 5

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

Continue Reading
Medicare Competitive Bidding May Slash Jobs, Access

Updated Category News Views 5

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Continue Reading
ScholarShare 529 Launches $50 Back-to-School Promo

Updated Category News Views 6

California Families Get a Boost With New 529 Plan Offer Everywhere you turn, it's 'back to school' mania right now, and ScholarShare 529 aims to ride that wave by sweetening the pot for parents ready to think ahead. So here's the gist—California's official college savings plan is handing out a $50 gift card for new accounts opened between now and September 30th. Setting...

Continue Reading
Finastra Recognized as 2026 Leader in Payment Platforms

Updated Category News Views 5

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

Continue Reading
Ransoms and Mega-Losses Surge in Cyber Claims Study

Updated Category News Views 5

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

Continue Reading

Top 5 Most Recently Viewed Articles

Silex Technology Launches Innovative SoM for Edge-AI Use

Updated Category News Views 242

Silex Technology Introduces Cutting-Edge SoM for Industries At the recent Embedded World 2025 event, Silex Technology made headlines with the unveiling of the AMC Edge System-on-Module (SoM), designated EP-200Q. This state-of-the-art module excels in providing high-performance Wi-Fi 7 connectivity tailored for industrial AI applications. Overview of the AMC Edge...

Continue Reading
Trisura Group Posts Record Annual Results, Reflecting Growth

Updated Category News Views 94

Trisura Group Achieves Impressive Fourth Quarter Results Trisura Group Ltd. (TSX: TSU), a recognized leader in specialty insurance, has recently disclosed remarkable financial results for its fourth quarter and the entire year. The company reported an operating net income of $38.2 million for the quarter, translating to approximately $0.79 per share. This achievement...

Continue Reading
Hudson Global Set to Release Q4 2024 Results and Insights

Updated Category News Views 264

Hudson Global to Release Fourth Quarter Financial Results Hudson Global, Inc. (NASDAQ: HSON), a prominent name in the talent solutions industry, is gearing up to announce its financial results for the fourth quarter, which ended on December 31, 2024. The announcement is set to take place before the market opens on a specified date in March 2025. Join the Upcoming...

Continue Reading
Navigating Through Revelation: A Guide by Stephen J. Knowlton

Updated Category News Views 88

Understanding Revelation: A Comprehensive Roadmap Xulon Press introduces a captivating look into the book of Revelation, uncovering the many intricate visions it presents. Author Stephen J. Knowlton has dedicated over 50 years to understanding this profound biblical text, which at first glance can be overwhelmingly perplexing. His latest work, Choose Your Rapture: The...

Continue Reading
Free Kaplan Test Prep for Grad School Offered to Students

Updated Category News Views 266

Transformative Educational Opportunities for Students Exciting news is on the horizon for students at various member institutions of the Association for Program Administrators of CSTEP and STEP, Inc. They will have access to free Kaplan test preparation courses aimed at graduate-level admissions examinations. This initiative is a significant step towards supporting...

Continue Reading